ArticleAsian journal of andrology

Exploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinib.

Himisha Beltran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.